KalVista Pharmaceuticals (KALV) Earnings (2014 - 2026)
KalVista Pharmaceuticals (KALV) earnings from Mar 31, 2014 to Mar 31, 2026. The TTM KalVista Pharmaceuticals (KALV) earnings is -$191M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
KalVista Pharmaceuticals (KALV) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -27.36% |
| 3 Years TTM | +28.10% |
| 5 Years TTM | +38.16% |
| 10 Years TTM | +23.22% |
| All Time TTM | +24.91% |
Annual Earnings change of KalVista Pharmaceuticals (KALV)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$23M | -87.19% |
| 2025 | -$183M | +44.85% |
| 2024 | -$127M | +36.30% |
| 2023 | -$93M | +12.84% |
| 2022 | -$82M | +78.07% |
| 2021 | -$46M | +58.79% |
| 2020 | -$29M | +39.87% |
| 2019 | -$21M | +530.91% |
| 2018 | -$3.30M | -33.87% |
| 2017 | -$4.99M | N/A |
| 2016 | $0 | -100.00% |
| 2015 | -$25M | +86.00% |
| 2014 | -$13M | +135.21% |
| 2013 | -$5.68M | N/A |
Comparison KalVista Pharmaceuticals (KALV) five years earnings CAGR with competitors
KalVista Pharmaceuticals (KALV) five years earnings CAGR is 18.29%.